Fig. 3From: Using focused pharmacovigilance for ensuring patient safety against antileishmanial drugs in Bangladesh’s National Kala-azar Elimination Programmea Unexpected serious adverse event: Anular corneal ulcer. b Unexpected serious adverse event: Morren’s ulcer. c Unexpected serious adverse event: Avascular necrosis of the nasal alaeBack to article page